Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit. (IMPROVE)
Primary Purpose
Preoxygenation, Intubation, Intensive Care Unit
Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Preoxygenation
Preoxygenation (longer)
Sponsored by
About this trial
This is an interventional other trial for Preoxygenation focused on measuring preoxygenation, intubation, end-tidal of oxygen concentration, intensive care unit, critically ill patients
Eligibility Criteria
Inclusion Criteria:
- Patients older than 18 years
- Requiring intubation in ICU
- Free express oral and informed consent of the patient or a proxy in case of impossibility for the patient to consent; emergency inclusion possible when legal representatives and patient's family are not present
Exclusion Criteria:
- Intubation for cardiac arrest
- End-tidal oxygen concentration monitoring not available
- Preoxygenation with high-flow nasal oxygenation
- Previous participation to the study
- Patient known, at time of inclusion, as being under guardianship, tutorship or curator
- Pregnancy or breastfeeding
- Lack of social security number
Sites / Locations
- CH de DAX
- CHR d'Orléans
- CHRU de TOURS
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
3 minutes period of preoxygenation
5 minutes period of preoxygenation
Arm Description
3 minutes of preoxygenation : participants in this group will receive 3 minutes of preoxygenation before intubation
5 minutes of preoxygenation: participants in this group will receive 5 minutes of preoxygenation before intubation
Outcomes
Primary Outcome Measures
Percentage of patients who reach an EtO2 of 90%
To compare the percentage of patients who reach an EtO2 of 90% or higher (optimal preoxygenation) at the end of the preoxygenation period between patients randomized in the 3-min and those randomized in the 5-min preoxygenation duration group.
Secondary Outcome Measures
Expired oxygen fraction (FeO2)
FeO2 will be recorded at the end of the preoxygenation period
Incidence of hypoxemia
Hypoxemia will be defined by SpO2<90% during the intubation procedure
Incidence of severe hypoxemia
Severe hypoxemia will be defined by SpO2<80% for more than 5 seconds during the intubation procedure from the end of preoxygenation to 5 minutes after invasive mechanical ventilation
Incidence of severe complications
Severs complications occuring within 30 minutes following the intubation procedure will be evaluate and compare between the two groups
Lowest Pulsed saturation with Oxygen (SpO2)
The lowest SPO2 obtained within 30 minutes after the end of preoxygenation will be compared between the 2 groups
Expired oxygen fraction (FeO2)
FeO2 during preoxygenation will be recorded every minutes
Partial Pressure of Oxygen (PaO2)
Measurement of PaO2
Partial Pressure of Oxygen
Measurement of PaO2 at the end of the preoxygenation
Full Information
NCT ID
NCT04148443
First Posted
September 5, 2019
Last Updated
July 19, 2023
Sponsor
Centre Hospitalier Régional d'Orléans
1. Study Identification
Unique Protocol Identification Number
NCT04148443
Brief Title
Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit.
Acronym
IMPROVE
Official Title
Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit.
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
December 2023 (Anticipated)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Régional d'Orléans
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Preoxygenation is recommended before performing tracheal intubation. In intensive care units (ICU) patients, there is no specific recommendation regarding the duration of preoxygenation, which usually is applied for 3 to 5 minutes. Monitoring the effectiveness of preoxygenation with end-tidal oxygen concentration (EtO2) is strongly recommended in the operating room but it is never used in ICUs. The first aim of this pilot study is to assess the effect of the preoxygenation duration on EtO2, and secondarily, as an exploratory objective, to determine whether targeting a given value of EtO2 during preoxygenation might insure a safer intubation than when targeting pulse oximetry (SpO2).
Detailed Description
This is a multicenter randomized controlled pilot study. 110 patients who require intubation in the ICU will be randomly assigned, with a 1:1 ratio, to 3 or 5 minutes of preoxygenation duration. EtO2 will be continuously measured but hidden to the clinician. The primary outcome measure will be the obtention of an optimal preoxygenation defined by an EtO2 >90%. Secondary outcomes include the occurrence of hypoxia and complications during the procedure.
A pulse oximetry (SpO2) greater than or equal to 96% (SpO2 ≥ 96%) at the end of preoxygenation will be the target in each group. If at the end of the preoxygenation, SpO2 is still lower than 96%, clinician will be allowed to extend the duration of preoxygenation (up to 5 minutes in the 3 minutes period of preoxygenation group and up to 8 minutes in the 5 minutes period of preoxygenation group).
End-tidal oxygen concentration (EtO2) will be measured during preoxygenation and will be hidden to the clinician in order to not influence the duration of preoxygenation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preoxygenation, Intubation, Intensive Care Unit
Keywords
preoxygenation, intubation, end-tidal of oxygen concentration, intensive care unit, critically ill patients
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Pilot study Randomized controlled multicenter trial Ratio 1:1
Masking
None (Open Label)
Allocation
Randomized
Enrollment
110 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
3 minutes period of preoxygenation
Arm Type
Experimental
Arm Description
3 minutes of preoxygenation : participants in this group will receive 3 minutes of preoxygenation before intubation
Arm Title
5 minutes period of preoxygenation
Arm Type
Experimental
Arm Description
5 minutes of preoxygenation: participants in this group will receive 5 minutes of preoxygenation before intubation
Intervention Type
Other
Intervention Name(s)
Preoxygenation
Intervention Description
participants will receive 3 minutes of preoxygenation before intubation
Intervention Type
Other
Intervention Name(s)
Preoxygenation (longer)
Intervention Description
participants will receive 5 minutes of preoxygenation before intubation
Primary Outcome Measure Information:
Title
Percentage of patients who reach an EtO2 of 90%
Description
To compare the percentage of patients who reach an EtO2 of 90% or higher (optimal preoxygenation) at the end of the preoxygenation period between patients randomized in the 3-min and those randomized in the 5-min preoxygenation duration group.
Time Frame
3 minutes
Secondary Outcome Measure Information:
Title
Expired oxygen fraction (FeO2)
Description
FeO2 will be recorded at the end of the preoxygenation period
Time Frame
end of the preoxygenation period
Title
Incidence of hypoxemia
Description
Hypoxemia will be defined by SpO2<90% during the intubation procedure
Time Frame
5 minutes after intubation
Title
Incidence of severe hypoxemia
Description
Severe hypoxemia will be defined by SpO2<80% for more than 5 seconds during the intubation procedure from the end of preoxygenation to 5 minutes after invasive mechanical ventilation
Time Frame
End of preoxygenation
Title
Incidence of severe complications
Description
Severs complications occuring within 30 minutes following the intubation procedure will be evaluate and compare between the two groups
Time Frame
30 minutes after intubation
Title
Lowest Pulsed saturation with Oxygen (SpO2)
Description
The lowest SPO2 obtained within 30 minutes after the end of preoxygenation will be compared between the 2 groups
Time Frame
30 minutes after the end of preoxygenation
Title
Expired oxygen fraction (FeO2)
Description
FeO2 during preoxygenation will be recorded every minutes
Time Frame
Through preoxygenantion, i.e., an average of 4 minutes (a minimum of 3 and a maximum of 8 minutes)
Title
Partial Pressure of Oxygen (PaO2)
Description
Measurement of PaO2
Time Frame
0 minute
Title
Partial Pressure of Oxygen
Description
Measurement of PaO2 at the end of the preoxygenation
Time Frame
at the 4th minute on average (3rd or 5th minute depending on the randomisation group)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients older than 18 years
Requiring intubation in ICU
Free express oral and informed consent of the patient or a proxy in case of impossibility for the patient to consent; emergency inclusion possible when legal representatives and patient's family are not present
Exclusion Criteria:
Intubation for cardiac arrest
End-tidal oxygen concentration monitoring not available
Preoxygenation with high-flow nasal oxygenation
Previous participation to the study
Patient known, at time of inclusion, as being under guardianship, tutorship or curator
Pregnancy or breastfeeding
Lack of social security number
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Aurélie DESPUJOLS
Phone
0033238744071
Email
aurelie.despujols@chr-orleans.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Elodie TATSI TOTOUOM
Phone
0033238744086
Email
elodie.tatsi-totouom@chr-orleans.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mai-ANh NAY, MD
Organizational Affiliation
CHR Orléans
Official's Role
Principal Investigator
Facility Information:
Facility Name
CH de DAX
City
Dax
ZIP/Postal Code
40100
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adrien AUVET, Dr
Facility Name
CHR d'Orléans
City
Orléans
ZIP/Postal Code
45067
Country
France
Facility Name
CHRU de TOURS
City
Tours
ZIP/Postal Code
37000
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stephan EHRMANN, Pr
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
22318634
Citation
Carrillo A, Gonzalez-Diaz G, Ferrer M, Martinez-Quintana ME, Lopez-Martinez A, Llamas N, Alcazar M, Torres A. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med. 2012 Mar;38(3):458-66. doi: 10.1007/s00134-012-2475-6. Epub 2012 Feb 9.
Results Reference
background
PubMed Identifier
24962719
Citation
Thille AW, Frat JP, Brun-Buisson C. Trends in use and benefits of non-invasive ventilation as first-line therapy in acute respiratory failure. Intensive Care Med. 2014 Aug;40(8):1179-80. doi: 10.1007/s00134-014-3370-0. Epub 2014 Jun 25. No abstract available.
Results Reference
background
PubMed Identifier
24480997
Citation
Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Use and outcomes of noninvasive positive pressure ventilation in acute care hospitals in Massachusetts. Chest. 2014 May;145(5):964-971. doi: 10.1378/chest.13-1707.
Results Reference
background
Learn more about this trial
Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit.
We'll reach out to this number within 24 hrs